Jan 12 (Reuters) - Glaxosmithkline Plc:
* GSK RECEIVES FDA APPROVAL FOR EXPANDED INDICATION FOR FLUARIXÂ® QUADRIVALENT (INFLUENZA VACCINE) FOR PERSONS 6 MONTHS AND OLDER Source text for Eikon: Further company coverage:
 